Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2026-01-06 @ 2:51 AM
Study NCT ID:
NCT05081193
Status:
COMPLETED
Last Update Posted:
2025-09-22
First Post:
2021-10-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-04
First Submit QC Date:
None
Study First Post Date:
2021-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-18
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED